back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-02-06 21:42 Tx date 2022-01-13 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
400,000 | |
| Filed 2024-02-06 21:42 Tx date 2022-01-13 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
300,000 | |
| Filed 2022-01-13 16:14 Tx date 2021-12-31 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
||
| Filed 2022-01-13 16:07 Tx date 2021-12-31 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2022-02-22 16:03 Tx date 2022-02-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+400,000 vol |
2,115,000 | |
| Filed 2022-02-22 15:59 Tx date 2022-02-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-100,000
-400,000 vol $0.25 each |
-250,000 | |
| Filed 2022-02-22 08:28 Tx date 2022-02-18 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$26,500
+106,000 vol $0.25 each |
706,000 | |
| Filed 2022-02-22 08:14 Tx date 2022-02-18 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$26,500
+106,000 vol $0.25 each |
600,000 | |
| Filed 2022-02-21 10:22 Tx date 2022-02-18 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
+400,000 vol |
||
| Filed 2022-02-21 10:10 Tx date 2022-02-18 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
+400,000 vol |
||
| Filed 2022-02-10 15:35 Tx date 2022-02-10 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$144,000
+200,000 vol $0.72 each |
1,715,000 | |
| Filed 2022-02-10 15:32 Tx date 2022-02-07 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$81,950
+110,000 vol $0.74 each |
1,515,000 | |
| Filed 2022-02-08 18:38 Tx date 2022-02-03 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$23,500
+94,000 vol $0.25 each |
234,000 | |
| Filed 2022-02-08 18:30 Tx date 2022-02-03 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$23,500
+94,000 vol $0.25 each |
494,000 | |
| Filed 2022-01-19 11:19 Tx date 2022-01-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
+200,000 vol |
1,405,000 | |
| Filed 2022-01-19 11:17 Tx date 2022-01-14 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-50,000
-200,000 vol $0.25 each |
150,000 | |
| Filed 2022-01-13 16:14 Tx date 2021-12-31 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
400,000 | |
| Filed 2022-01-13 16:07 Tx date 2021-12-31 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
300,000 | |
| Filed 2021-10-01 17:33 Tx date 2021-10-01 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$66,310
+95,000 vol $0.70 each |
1,205,000 | |
| Filed 2021-10-01 17:26 Tx date 2021-09-29 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$28,400
+40,000 vol $0.71 each |
1,110,000 | |
| Filed 2021-06-09 11:03 Tx date 2021-06-07 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Black (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$225,000
+300,000 vol $0.75 each |
300,000 | |
| Filed 2021-06-09 10:53 Tx date 2021-06-04 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,040
+24,000 vol $0.96 each |
1,050,000 | |
| Filed 2021-06-09 10:46 Tx date 2021-06-07 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$15,000
+20,000 vol $0.75 each |
1,070,000 | |
| Filed 2021-06-09 10:43 Tx date 2021-06-04 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,200
+20,000 vol $0.96 each |
||
| Filed 2021-06-08 18:31 Tx date 2021-06-03 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$15,000
+20,000 vol $0.75 each |
40,000 | |
| Filed 2021-06-08 18:20 Tx date 2021-06-03 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$15,000
+20,000 vol $0.75 each |
140,000 | |
| Filed 2021-05-06 14:21 Tx date 2021-05-05 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,200
+20,000 vol $1.01 each |
219,400 | |
| Filed 2021-05-06 12:58 Tx date 2021-05-05 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,000
+20,000 vol $1.10 each |
219,400 | |
| Filed 2021-05-06 12:58 Tx date 2021-05-05 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$22,000
+20,000 vol $1.10 each |
||
| Filed 2021-05-06 12:57 Tx date 2021-05-05 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$40,000
+40,000 vol $1.00 each |
199,400 | |
| Filed 2021-04-26 12:42 Tx date 2021-04-23 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$100,000
+100,000 vol $1.00 each |
159,400 | |
| Filed 2021-03-18 18:06 Tx date 2021-03-17 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$26,250
+25,000 vol $1.05 each |
59,400 | |
| Filed 2021-03-18 18:05 Tx date 2021-03-17 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,984
+2,800 vol $1.07 each |
34,400 | |
| Filed 2021-03-18 18:04 Tx date 2021-03-17 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,930
+6,600 vol $1.05 each |
31,600 | |
| Filed 2021-03-12 16:39 Tx date 2021-03-12 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,420
+21,000 vol $1.02 each |
25,000 | |
| Filed 2021-03-12 16:38 Tx date 2021-03-12 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,011
+4,000 vol $1.00 each |
4,000 | |
| Filed 2021-03-12 16:37 Tx date 2018-04-11 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: RRSP (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-01-31 23:50 Tx date 2021-01-11 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
400,000 | |
| Filed 2021-01-31 23:49 Tx date 2021-01-11 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
120,000 | |
| Filed 2021-01-31 23:45 Tx date 2021-01-10 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-25,000
-100,000 vol $0.25 each |
||
| Filed 2021-01-31 23:09 Tx date 2020-07-22 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$80,000
+100,000 vol $0.80 each |
500,000 | |
| Filed 2021-01-21 21:57 Tx date 2021-01-21 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+95,000 vol |
1,026,000 | |
| Filed 2021-01-20 17:35 Tx date 2021-01-20 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+111,000 vol |
931,000 | |
| Filed 2021-01-04 16:58 Tx date 2020-12-30 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$100,000 vol $0.80 each |
$100,000 | |
| Filed 2021-01-04 16:57 Tx date 2020-12-30 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$122,999
+150,000 vol $0.82 each |
350,000 | |
| Filed 2021-01-04 16:54 Tx date 2020-12-30 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$125,000
+125,000 vol $1.00 each |
545,000 | |
| Filed 2021-01-04 16:43 Tx date 2020-12-31 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
11 - Acquisition or disposition carried out privately
|
$
+$100,000 vol $0.80 each |
||
| Filed 2021-01-04 15:58 Tx date 2018-04-11 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-08-28 17:21 Tx date 2020-08-19 |
$PILL
Canntab Therapeutics Limited |
Latowsky, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
744,000 | ||
| Filed 2020-08-28 17:08 Tx date 2020-08-19 |
$PILL
Canntab Therapeutics Limited |
Latowsky, Larry
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
244,000 | ||
| Filed 2020-03-05 11:00 Tx date 2020-02-28 |
$PILL
Canntab Therapeutics Limited |
Polisuk, Barry
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Barry M. Polisuk Professional Corporation (Indirect Ownership)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+20,000 vol $0.50 each |
20,000 | |
| Filed 2020-03-05 10:52 Tx date 2020-02-28 |
$PILL
Canntab Therapeutics Limited |
Polisuk, Barry
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+20,000 vol $0.50 each |
||
| Filed 2020-03-05 10:41 Tx date 2018-04-11 |
$PILL
Canntab Therapeutics Limited |
Polisuk, Barry
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Barry M. Polisuk Professional Corporation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-05 10:27 Tx date 2020-02-28 |
$PILL
Canntab Therapeutics Limited |
Polisuk, Barry
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Barry M. Polisuk Professional Corporation (Indirect Ownership)
|
Warrants
11 - Acquisition or disposition carried out privately
|
$15,000
+20,000 vol $0.75 each |
20,000 | |
| Filed 2020-03-05 10:26 Tx date 2018-04-11 |
$PILL
Canntab Therapeutics Limited |
Polisuk, Barry
4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Barry M. Polisuk Professional Corporation (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-05 10:22 Tx date 2020-02-27 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$15,000
+20,000 vol $0.75 each |
420,000 | |
| Filed 2020-03-05 10:16 Tx date 2020-02-27 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$15,000
+20,000 vol $0.75 each |
20,000 | |
| Filed 2020-03-05 10:10 Tx date 2018-04-11 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-03 10:13 Tx date 2020-02-28 |
$PILL
Canntab Therapeutics Limited |
Polisuk, Barry
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+20,000 vol $0.50 each |
||
| Filed 2020-03-03 10:13 Tx date 2020-02-28 |
$PILL
Canntab Therapeutics Limited |
Polisuk, Barry
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+20,000 vol $0.50 each |
340,000 | |
| Filed 2020-03-03 10:12 Tx date 2020-02-27 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+20,000 vol $0.50 each |
20,000 | |
| Filed 2020-03-03 10:11 Tx date 2018-04-11 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-03-03 10:08 Tx date 2020-02-27 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+20,000 vol $0.50 each |
820,000 | |
| Filed 2019-10-24 15:23 Tx date 2019-02-21 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$100,000
+400,000 vol $0.25 each |
400,000 | |
| Filed 2019-10-24 15:21 Tx date 2018-04-11 |
$PILL
Canntab Therapeutics Limited |
Fonseca, Vitor M
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-07-17 Tx date 2018-07-17 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Black (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
-20,000 vol |
0 | |
| Filed 2018-06-07 Tx date 2018-04-11 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Black (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-06-07 Tx date 2018-06-04 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Black (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,481
+7,000 vol $0.78 each |
7,000 | |
| Filed 2018-06-07 Tx date 2018-06-04 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Black (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,379
+3,000 vol $0.79 each |
10,000 | |
| Filed 2018-06-07 Tx date 2018-06-05 |
$PILL
Canntab Therapeutics Limited |
Goldstein, Richard
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Holder: Cindy Black (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,680
+10,000 vol $0.77 each |
20,000 | |
| Filed 2018-06-06 Tx date 2018-06-01 |
$PILL
Canntab Therapeutics Limited |
Inwentash, Sheldon
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$100,000
+400,000 vol $0.25 each |
874,500 | |
| Filed 2018-06-05 Tx date 2018-06-01 |
$PILL
Canntab Therapeutics Limited |
Inwentash, Sheldon
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-400,000 vol |
25,000 |